Micron Technology (MU) shares fell to $339 Monday as fears over Alphabet’s (GOOGL) TurboQuant AI memory-compression algorithm raised concerns about long-term demand for high-bandwidth memory across ...
The compression algorithm works by shrinking the data stored by large language models, with Google’s research finding that it can reduce memory usage by at least six times “with zero accuracy loss.” ...
As Large Language Models (LLMs) expand their context windows to process massive documents and intricate conversations, they encounter a brutal hardware reality known as the "Key-Value (KV) cache ...
Even if you don’t know much about the inner workings of generative AI models, you probably know they need a lot of memory. Hence, it is currently almost impossible to buy a measly stick of RAM without ...
A new study published today in Nature has found that X’s algorithm – the hidden system or “recipe” that governs which posts appear in your feed and in which order – shifts users’ political opinions in ...
In case you had any doubt, Elon Musk’s X has an algorithm that favors conservative content posted by political activists over liberal content or posts by traditional news media accounts, according to ...
Meta on Wednesday debuted an AI feature called "Dear Algo" that lets Threads users personalize their content-recommendation algorithms. Threads users will be able to tell the Dear Algo tool what kinds ...
The U.S. Food and Drug Administration (FDA) refused to consider Moderna’s application for a new flu vaccine using mRNA technology, the company announced Tuesday, a decision that could delay the ...
The Food and Drug Administration has refused to start a review of Moderna's application for its experimental flu shot, the company said. It's another sign of the Trump administration's influence on ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
The Food and Drug Administration has declined to review Moderna’s application for the first mRNA-based flu vaccine, a decision that shocked the company and that comes as the agency plans to tighten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results